Manganese‐Enhanced Magnetic Resonance Imaging of the Heart
Journal of Magnetic Resonance Imaging · 2023-04 · 57 (4) · 1011-1028
DOI: 10.1002/jmri.28499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 31.10.2022. Verfasst von Trisha Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: BHF/University Centre for Cardiovascular Science, University of Edinburgh, UK. Hauptthemen laut MEDLINE: Manganese, Cardiomyopathies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Manganese‐based contrast media were the first in vivo paramagnetic agents to be used in magnetic resonance imaging (MRI). The uniqueness of manganese lies in its biological function as a calcium channel analog, thus behaving as an intracellular contrast agent. Manganese ions are taken up by voltage‐gated calcium channels in viable tissues, such as the liver, pancreas, kidneys, and heart, in response to active calcium‐dependent cellular processes. Manganese‐enhanced magnetic resonance imaging (MEMRI) has therefore been used as a surrogate marker for cellular calcium handling and interest in its potential clinical applications has recently re‐emerged, especially in relation to assessing cellular viability and myocardial function. Calcium homeostasis is central to myocardial contraction and dysfunction of myocardial calcium handling is present in various cardiac pathologies. Recent studies have demonstrated that MEMRI can detect the presence of abnormal myocardial calcium handling in patients with myocardial infarction, providing clear demarcation between the infarcted and viable myocardium. Furthermore, it can provide more subtle assessments of abnormal myocardial calcium handling in patients with cardiomyopathies and being excluded from areas of nonviable cardiomyocytes and severe fibrosis. As such, MEMRI offers exciting potential to improve cardiac diagnoses and provide a noninvasive measure of myocardial function and contractility. This could be an invaluable tool for the assessment of both ischemic and nonischemic cardiomyopathies as well as providing a measure of functional myocardial recovery, an accurate prediction of disease progression and a method of monitoring treatment response. Evidence Level: 5 Technical Efficacy: Stage 5
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BHF/University Centre for Cardiovascular Science, University of Edinburgh, UK.
- Edinburgh Heart Centre, Royal Infirmary of Edinburgh, UK.
- Edinburgh Imaging, University of Edinburgh, UK.
ORCID-Profile: Trisha Singh, Lucy E Kershaw, David E Newby
Förderung
- British Heart Foundation
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Singh, T., Joshi, S., Kershaw, L. E., Dweck, M. R., Semple, S. I., & Newby, D. E. (2023). Manganese‐Enhanced Magnetic Resonance Imaging of the Heart. Journal of Magnetic Resonance Imaging, 57(4), 1011-1028. https://doi.org/10.1002/jmri.28499
Vancouver
Singh T, Joshi S, Kershaw LE, Dweck MR, Semple SI, Newby DE. Manganese‐Enhanced Magnetic Resonance Imaging of the Heart. Journal of Magnetic Resonance Imaging. 2023;57(4):1011-1028. doi:10.1002/jmri.28499
BibTeX
@article{Singh2023,
author = {Singh, Trisha and Joshi, Shruti and Kershaw, Lucy E and Dweck, Marc R and Semple, Scott I and Newby, David E},
title = {Manganese‐Enhanced Magnetic Resonance Imaging of the Heart},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
volume = {57},
number = {4},
pages = {1011--1028},
doi = {10.1002/jmri.28499}
}
EUVIMED